Clinical Trials Sponsored by Marlous Hall

Total 3765 results

Marlous Hall

Completed

Association of Long-term Conditions With Survival Following Heart Attack in England and Wales

Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Peripheral Vascular Disease | Chronic Heart Failure | Acute Myocardial Infarction | Chronic Renal Failure | Cerebrovascular Disease
Seton Hall University

Not yet recruiting

A Pilot Intervention Study to Promote Functional Health in Women

Health Behavior

United States
Seton Hall University

Unknown

Improve Functional Health Status in Minority Women With HIV

HIV/AIDS

United States
Willa Hall

Not yet recruiting

MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers

Adjustment Disorders | Post-Traumatic Stress Disorder
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Completed

Intestinal Dysmotility: Minute Rythm

Motility Disorder of Small Intestine (Disorder)

Spain
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Completed

Efficiency of Neurostimulation of Tibial Nerve in the Treatment of Low Anterior Resection Syndrome

Colorectal Surgery

Spain
Per Hall

Completed

Karma Intervention Study (Karisma 2)

Risk Reduction | Mammographic Density Reduction
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Completed

Readmissions of Lung Transplant Patients in ICU.

Lung Transplant; Complications
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Unknown

Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy (BETA)

Hepatic Encephalopathy | Cirrhosis

Spain
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Recruiting

Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy

Acute Ischemic Stroke

Spain
Hospital Universitari Vall d'Hebron Research Institute
Instituto de Salud Carlos III

Recruiting

Intestinal Dysmotility in Patients With Functional Digestive Symptoms

Gastrointestinal Motility Disorder

Spain
Marinus Pharmaceuticals

Active, not recruiting

Randomized Therapy In Status Epilepticus (RAISE)

Status Epilepticus

United States, Australia, Canada
Marinus Pharmaceuticals

Enrolling by invitation

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Tuberous Sclerosis Complex

United States, Spain, United Kingdom, China, Italy, France, Israel, Germany, Canada, Australia
Marinus Pharmaceuticals

Completed

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Mental Disorder | Postpartum Disorder | PPD | Postpartum Blues

United States
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (TSC)

Tuberous Sclerosis

United States
Marinus Pharmaceuticals

Completed

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 (0602)

Epilepsy, Complex Partial

United States
Vall d'Hebron Institute of Oncology
Prostate Cancer Foundation; Instituto de Salud Carlos III; Hospital Vall d'Hebron and other collaborators

Recruiting

Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer (iPROMET)

Prostate Cancer Metastatic

Spain
Marinus Pharmaceuticals

Withdrawn

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Refractory Status Epilepticus

Spain, Switzerland, Germany, France, Austria, Italy, Belgium, United Kingdom, Czechia, Croatia, Finland, Lithuania, Israel, Hungary, Poland, Slovakia
Marinus Pharmaceuticals

Withdrawn

Safety and Efficacy Study of IV Ganaxolone as Adjuvant Therapy for Established Status Epilepticus (ESE)

Status Epilepticus

United States
Marinus Pharmaceuticals

No longer available

Ganaxolone Expanded Access Program Compassionate Use (CDD)

CDKL5 Disorder
Marinus Pharmaceuticals

Completed

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Puerperal Disorders | Postpartum | PPD

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

PCDH19-Related Epilepsy

United States, Hungary, Italy, Netherlands, Poland
Marinus Pharmaceuticals

Completed

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

Epilepsy | Status Epilepticus | Convulsive Status EPILEPTICUS | Non Convulsive Status Epilepticus

United States
Marinus Pharmaceuticals

Not yet recruiting

Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old

CDKL5 Deficiency Disorder
Marinus Pharmaceuticals

Active, not recruiting

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy (TrustTSC)

Tuberous Sclerosis Complex

United States, Spain, United Kingdom, Israel, Italy, Germany, France, Canada
Marinus Pharmaceuticals

Terminated

A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures

Drug Resistant Partial Onset Seizure

United States
Marinus Pharmaceuticals

Terminated

Open-label Extension to Protocol 1042-0500

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder (Marigold)

CDKL5 Deficiency Disorder

United States, Australia, France, Israel, Italy, Poland, Russian Federation, United Kingdom
Marinus Pharmaceuticals

Completed

Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies

Epilepsy

United States, Italy
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Partial Epilepsy | Catamenial Epilepsy

United States
Marinus Pharmaceuticals

Completed

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Drug Resistant Partial Onset Seizure

United States, Australia, Russian Federation, Bulgaria, Germany, Poland
Marinus Pharmaceuticals

Completed

Open-label Extension to Protocol 1042-0600

Epilepsies, Partial

United States
Ong Fujian Chinese Physician Hall

Unknown

Effect of Electroacupuncture on P6 Acupoint on Hypertensive Patients. (EEP6)

Hypertension

Singapore
HALO Diagnostics
HALO Affiliate Sites

Recruiting

Phase I Human Analytics (HALO) Study (HALO)

Cardiovascular Diseases | Cancer | Dementia | Traumatic Brain Injury

United States
Marcus Migura
Mercy Health

Completed

A Transparent Elasticized Adhesive Occlusive Compression Bandage for Use as an Arterial Tourniquet

Hemorrhage | Vascular Injury

United States
HALO Diagnostics

Completed

A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer

Prostate Cancer

United States
HALO Diagnostics

Active, not recruiting

Phase II Laser Focal Therapy of Prostate Cancer (LITT or FLA)

Prostate Cancer

United States
Hill-Rom

Completed

AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries

Pressure Ulcer

United States
Hill-Rom

Completed

MN4000 for Treatment of CF and MND Patients in the Home Setting

Motor Neuron Disease | Cystic Fibrosis | Airway Clearance Impairment

United States
Hill-Rom

Completed

Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds

Pressure Ulcers

United States
Hill-Rom

Completed

Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations

Cerebral Palsy

United States
Hill-Rom

Completed

P400 for Stage II-IV Pressure Ulcers in Home and Extended Care (P400)

Pressure Ulcers

United States
Hill-Rom

Completed

Holy Name Progressive Mobility in the ICU

Respiratory Failure

United States
Hill-Rom

Withdrawn

Bronchiectasis: Evaluation of an Educational Intervention

Bronchiectasis

United States
Hill-Rom

Completed

A Pilot Study of the Envision® Surface

Pressure Ulcers

United States
Hill-Rom

Unknown

A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting

Bronchiectasis | Bronchiectasis With Acute Exacerbation

United States
Hill-Rom

Completed

Evaluation of an Airway Clearance System

Cystic Fibrosis

Belgium
Hill-Rom

Completed

HFCWO in Hospitalized Asthmatic Children

Asthma | Bronchial Asthma | Status Asthmaticus

United States
Hill-Rom

Completed

Early Progressive Mobility in the CVICU: Assessing Current Status

Immobility and Weakness Associated With Long Intensive Care Unit Stays

United States

Clinical Trials Sponsored by Marlous Hall

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations